Dermatology Clinic, 81st Medical Group, 81 MDOS/SGOMD, 301 Fisher Street, Keesler AFB, MS 39534, USA.
Dermatol Clin. 2012 Jul;30(3):469-85. doi: 10.1016/j.det.2012.04.008.
The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis.
目前，美国癌症联合委员会（AJCC）定义的黑色素瘤分期系统是确定黑色素瘤预后的标准。本文重点介绍 AJCC 黑色素瘤分期系统中与患者预后相关的组成部分。此外，本文还总结了其他常见的临床和组织学黑色素瘤预后因素，并回顾了与预后相关的遗传生物标志物的最新进展。
